The Trump administration claims the president’s blueprint to tackle high drug prices is already sparking a “sea change” that’s prompting pharmaceutical companies to lower prices.
Since Trump outlined the blueprint in May, there have been 60 percent fewer price hikes for brand name drugs compared to the same period in 2017, the administration said in a report released Monday 100 days after it was released. There have also been 54 percent more generic and brand drug price decreases compared to the same period in 2017.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.